Integer to Highlight Innovations in Neuromodulation, Next Generation of Miniaturized Active Implantable Devices During NANS 2025 Annual Meeting
28 1월 2025 - 10:38PM
Integer Holdings Corporation (NYSE: ITGR), one of the largest
medical device contract development and manufacturing organizations
(CDMO) in the world, will join global medtech leaders and
innovators in exhibiting at the North American Neuromodulation
Society (NANS) Annual Meeting in Orlando, Florida, from Jan. 30 –
Feb. 1, 2025.
NANS attendees are invited to visit booth #213 to learn more
about how Integer can serve as a strategic partner of choice in
amplifying customers’ innovation and increasing speed to market.
More specifically, Integer will showcase its latest innovations and
expanded capabilities in neuromodulation to enable the next
generation of miniaturized active implantable medical devices
(AIMDs).
“Through miniaturization, Integer is creating the next
generation of differentiated platform technologies to accelerate
and de-risk OEMs’ path to market for novel implantable medical
devices,” said Jim Stephens, President, Cardiac Rhythm Management
& Neuromodulation. “Our broad expertise in critical implantable
technologies—from batteries to fully integrated implantable pulse
generator systems—uniquely positions Integer to deliver
advancements in miniaturized AIMD technologies and help enable our
customers’ future therapies. We look forward to discussing this and
more at NANS.”
During NANS, attendees can also learn more about Integer’s
Xcellion® Gen 3 Fast Charge (FC) Lithium Ion implantable battery
technology. Xcellion Gen 3 FC delivers best in class battery
runtime and full re-charges in as little as 30 minutes.
Learn more about Integer at www.integer.net.
About Integer®Integer Holdings
Corporation (NYSE: ITGR) is one of the largest medical device
contract development and manufacturing organizations (CDMO) in the
world, serving the cardiac rhythm management, neuromodulation, and
cardio and vascular markets. As a strategic partner of choice to
medical device companies and OEMs, the Company is committed to
enhancing the lives of patients worldwide by providing innovative,
high-quality products and solutions. The Company's brands include
Greatbatch Medical® and Lake Region
Medical®. Additional information is available
at www.integer.net.
Investor Relations: |
Media
Relations: |
Andrew Senn |
Kelly Butler |
andrew.senn@integer.net |
kelly.butler@integer.net |
763.951.8312 |
469.731.6617 |
Integer (NYSE:ITGR)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Integer (NYSE:ITGR)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025